Karl-Olof Borg
Direttore/Membro del Consiglio presso BioCrine AB
Provenienza dei contatti di primo grado di Karl-Olof Borg
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
BioCrine AB
5
| Subsidiary | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Karl-Olof Borg tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
TENGION, INC. | Biotechnology | Director/Board Member | |
Premier Research Group Ltd.
Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal | |
Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
OREXO AB | Pharmaceuticals: Major | Chairman | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
University of Uppsala | College/University | Doctorate Degree | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | President | |
University of Stockholm | College/University | Masters Business Admin | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman | |
University of Lund | College/University | Undergraduate Degree | |
International Institute for Management Development | College/University | Undergraduate Degree | |
VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The European Society of Cardiology | Director/Board Member | ||
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
IMMUNOVIA AB | Pharmaceuticals: Major | Director/Board Member | |
BioFactor Therapeutics AB | Chief Executive Officer | ||
Astra Hässle AB | Chief Executive Officer | ||
Pan Capital AB
Pan Capital AB Financial ConglomeratesFinance Pan Capital AB operates as an investment company. It trades and manages securities and other financial instruments. The company was founded in 1998 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Chief Executive Officer | |
Erik Penser AB
Erik Penser AB Financial ConglomeratesFinance Part of Urdar AB, Erik Penser AB is a Swedish company that provides investment services. The company is based in Stockholm, Sweden. | Financial Conglomerates | Chairman | |
Stockholm Chamber of Commerce
Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
The Royal Bachelors' Club | Corporate Officer/Principal | ||
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Swedish Academy For Pharmaceutical Sciences | Corporate Officer/Principal | ||
Star Stable Entertainment AB
Star Stable Entertainment AB Packaged SoftwareTechnology Services Star Stable Entertainment AB engages in the development of a multi-player adventure game. It offers Star Stable Online, an online horse adventure set; Star Stable Music, which works with female talent to bring life to the in game on and offline; Star Stable Friends, which enables users to send messages with friends; and Star Stable Books, which provides YA fantasy trilogy Soul Riders. The company was founded by Eric Johan Werner Edfeldt, Carl Peter Thomas Liljestrand and Bror Ola Ahlvar Ahlvarsson in 2011 and is headquartered in Stockholm, Sweden. | Packaged Software | Chairman | |
Nicklasson Life Science AB | Corporate Officer/Principal | ||
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chairman | |
Mixmo AB | Director/Board Member | ||
CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
Svipdag AB | Director/Board Member | ||
Farma Investment AS
Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Real Estate Investment Trusts | Chairman | |
Biocrine Regenative Medicine Aktiebolag | Chairman | ||
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Olsson Solutions AB | Director/Board Member | ||
Betagenon Bio AB | Chairman | ||
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
K2A KNAUST & ANDERSSON FASTIGHETER AB | Real Estate Development | Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 40 |
Regno Unito | 4 |
Svizzera | 4 |
Norvegia | 3 |
Stati Uniti | 2 |
Settori
Health Technology | 23 |
Commercial Services | 7 |
Consumer Services | 6 |
Finance | 5 |
Technology Services | 2 |
Posizioni
Director/Board Member | 42 |
Chairman | 19 |
Chief Executive Officer | 17 |
Independent Dir/Board Member | 14 |
Corporate Officer/Principal | 13 |
Contatti più connessi
- Borsa valori
- Insiders
- Karl-Olof Borg
- Connessioni Società